Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Excellent News

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Nov 06, 2023 12:35pm

138 Views

Post# 35719641

RE:RE:RE:Excellent News

Eoganacht: You're one of the trusted voices here. Did you mean pre-BTD submission or BTD submission by year end? I'm not surprised if they pushed again without explicitly saying so. It's all moot if they can't raise money.

Eoganacht wrote: The great news is that Theralase has confirmed they will submit the BTD application before year end, they are now plainly stating that Ruvidar PDT is better than both FDA approved treatments Keytruda and Adstiladrin, and they treated one more patient. Just 37 patients to go.

Legit62 wrote: whats the great news Knoxt?? were they able to fill it??